FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:PTPRB-MYRFL

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PTPRB-MYRFL
FusionPDB ID: 70326
FusionGDB2.0 ID: 70326
HgeneTgene
Gene symbol

PTPRB

MYRFL

Gene ID

5787

196446

Gene nameprotein tyrosine phosphatase receptor type Bmyelin regulatory factor like
SynonymsHPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTPC12orf15|C12orf28|bcm1377
Cytomap

12q15

12q15

Type of geneprotein-codingprotein-coding
Descriptionreceptor-type tyrosine-protein phosphatase betaVE-PTPprotein tyrosine phosphatase, receptor type, beta polypeptidevascular endothelial protein tyrosine phosphatasemyelin regulatory factor-like protein
Modification date2020032720200322
UniProtAcc.

Q96LU7

Main function of 5'-partner protein:
Ensembl transtripts involved in fusion geneENST idsENST00000261266, ENST00000334414, 
ENST00000451516, ENST00000538708, 
ENST00000550358, ENST00000550857, 
ENST00000551525, ENST00000538174, 
ENST00000299350, ENST00000535034, 
ENST00000547771, ENST00000552032, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score2 X 2 X 2=829 X 16 X 7=3248
# samples 226
** MAII scorelog2(2/8*10)=1.32192809488736log2(26/3248*10)=-3.64296810415672
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: PTPRB [Title/Abstract] AND MYRFL [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: PTPRB [Title/Abstract] AND MYRFL [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PTPRB(70974816)-MYRFL(70345893), # samples:1
Anticipated loss of major functional domain due to fusion event.PTPRB-MYRFL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRB-MYRFL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRB-MYRFL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PTPRB-MYRFL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgenePTPRB

GO:0016311

dephosphorylation

19116766|19136612



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:70974816/chr12:70345893)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across PTPRB (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across MYRFL (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000451516PTPRBchr1270974816-ENST00000552032MYRFLchr1270345893+2355165402162720
ENST00000451516PTPRBchr1270974816-ENST00000547771MYRFLchr1270345893+2726165402159719
ENST00000451516PTPRBchr1270974816-ENST00000299350MYRFLchr1270345893+2355165402162720
ENST00000451516PTPRBchr1270974816-ENST00000535034MYRFLchr1270345893+2164165402087695
ENST00000334414PTPRBchr1270974816-ENST00000552032MYRFLchr1270345893+332426234531311028
ENST00000334414PTPRBchr1270974816-ENST00000547771MYRFLchr1270345893+369526234531281027
ENST00000334414PTPRBchr1270974816-ENST00000299350MYRFLchr1270345893+332426234531311028
ENST00000334414PTPRBchr1270974816-ENST00000535034MYRFLchr1270345893+313326234530561003
ENST00000550358PTPRBchr1270974816-ENST00000552032MYRFLchr1270345893+330526042631121028
ENST00000550358PTPRBchr1270974816-ENST00000547771MYRFLchr1270345893+367626042631091027
ENST00000550358PTPRBchr1270974816-ENST00000299350MYRFLchr1270345893+330526042631121028
ENST00000550358PTPRBchr1270974816-ENST00000535034MYRFLchr1270345893+311426042630371003
ENST00000538708PTPRBchr1270974816-ENST00000552032MYRFLchr1270345893+26541953202461813
ENST00000538708PTPRBchr1270974816-ENST00000547771MYRFLchr1270345893+30251953202458812
ENST00000538708PTPRBchr1270974816-ENST00000299350MYRFLchr1270345893+26541953202461813
ENST00000538708PTPRBchr1270974816-ENST00000535034MYRFLchr1270345893+24631953202386788
ENST00000550857PTPRBchr1270974816-ENST00000552032MYRFLchr1270345893+23841683202191723
ENST00000550857PTPRBchr1270974816-ENST00000547771MYRFLchr1270345893+27551683202188722
ENST00000550857PTPRBchr1270974816-ENST00000299350MYRFLchr1270345893+23841683202191723
ENST00000550857PTPRBchr1270974816-ENST00000535034MYRFLchr1270345893+21931683202116698
ENST00000261266PTPRBchr1270974816-ENST00000552032MYRFLchr1270345893+26551954212462813
ENST00000261266PTPRBchr1270974816-ENST00000547771MYRFLchr1270345893+30261954212459812
ENST00000261266PTPRBchr1270974816-ENST00000299350MYRFLchr1270345893+26551954212462813
ENST00000261266PTPRBchr1270974816-ENST00000535034MYRFLchr1270345893+24641954212387788
ENST00000551525PTPRBchr1270974816-ENST00000552032MYRFLchr1270345893+330126002531081027
ENST00000551525PTPRBchr1270974816-ENST00000547771MYRFLchr1270345893+367226002531051026
ENST00000551525PTPRBchr1270974816-ENST00000299350MYRFLchr1270345893+330126002531081027
ENST00000551525PTPRBchr1270974816-ENST00000535034MYRFLchr1270345893+311026002530331002

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000451516ENST00000552032PTPRBchr1270974816-MYRFLchr1270345893+0.0002781780.9997218
ENST00000451516ENST00000547771PTPRBchr1270974816-MYRFLchr1270345893+0.0001683170.9998317
ENST00000451516ENST00000299350PTPRBchr1270974816-MYRFLchr1270345893+0.0002781780.9997218
ENST00000451516ENST00000535034PTPRBchr1270974816-MYRFLchr1270345893+0.00058620.99941385
ENST00000334414ENST00000552032PTPRBchr1270974816-MYRFLchr1270345893+0.0002655460.99973446
ENST00000334414ENST00000547771PTPRBchr1270974816-MYRFLchr1270345893+0.0002052230.9997948
ENST00000334414ENST00000299350PTPRBchr1270974816-MYRFLchr1270345893+0.0002655460.99973446
ENST00000334414ENST00000535034PTPRBchr1270974816-MYRFLchr1270345893+0.0006141030.99938583
ENST00000550358ENST00000552032PTPRBchr1270974816-MYRFLchr1270345893+0.0002648820.99973506
ENST00000550358ENST00000547771PTPRBchr1270974816-MYRFLchr1270345893+0.000203370.9997967
ENST00000550358ENST00000299350PTPRBchr1270974816-MYRFLchr1270345893+0.0002648820.99973506
ENST00000550358ENST00000535034PTPRBchr1270974816-MYRFLchr1270345893+0.0006056110.9993944
ENST00000538708ENST00000552032PTPRBchr1270974816-MYRFLchr1270345893+0.00021380.9997862
ENST00000538708ENST00000547771PTPRBchr1270974816-MYRFLchr1270345893+0.0001322090.9998678
ENST00000538708ENST00000299350PTPRBchr1270974816-MYRFLchr1270345893+0.00021380.9997862
ENST00000538708ENST00000535034PTPRBchr1270974816-MYRFLchr1270345893+0.0003374740.9996625
ENST00000550857ENST00000552032PTPRBchr1270974816-MYRFLchr1270345893+0.0002726410.9997273
ENST00000550857ENST00000547771PTPRBchr1270974816-MYRFLchr1270345893+0.0001696950.99983025
ENST00000550857ENST00000299350PTPRBchr1270974816-MYRFLchr1270345893+0.0002726410.9997273
ENST00000550857ENST00000535034PTPRBchr1270974816-MYRFLchr1270345893+0.0005517390.99944824
ENST00000261266ENST00000552032PTPRBchr1270974816-MYRFLchr1270345893+0.0002121920.99978787
ENST00000261266ENST00000547771PTPRBchr1270974816-MYRFLchr1270345893+0.0001312650.99986875
ENST00000261266ENST00000299350PTPRBchr1270974816-MYRFLchr1270345893+0.0002121920.99978787
ENST00000261266ENST00000535034PTPRBchr1270974816-MYRFLchr1270345893+0.000333880.9996661
ENST00000551525ENST00000552032PTPRBchr1270974816-MYRFLchr1270345893+0.0002607040.9997392
ENST00000551525ENST00000547771PTPRBchr1270974816-MYRFLchr1270345893+0.0002026580.9997974
ENST00000551525ENST00000299350PTPRBchr1270974816-MYRFLchr1270345893+0.0002607040.9997392
ENST00000551525ENST00000535034PTPRBchr1270974816-MYRFLchr1270345893+0.0005026390.9994973

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for PTPRB-MYRFL

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
PTPRBchr1270974816MYRFLchr12703458931654551GISSRQVVVEGRTDKSKSVLARNALS
PTPRBchr1270974816MYRFLchr12703458931654551GISSRQVVVEGRTEDKSKSVLARNAL
PTPRBchr1270974816MYRFLchr12703458931683554GISSRQVVVEGRTDKSKSVLARNALS
PTPRBchr1270974816MYRFLchr12703458931683554GISSRQVVVEGRTEDKSKSVLARNAL
PTPRBchr1270974816MYRFLchr12703458931953644GISSRQVVVEGRTDKSKSVLARNALS
PTPRBchr1270974816MYRFLchr12703458931953644GISSRQVVVEGRTEDKSKSVLARNAL
PTPRBchr1270974816MYRFLchr12703458931954644GISSRQVVVEGRTDKSKSVLARNALS
PTPRBchr1270974816MYRFLchr12703458931954644GISSRQVVVEGRTEDKSKSVLARNAL
PTPRBchr1270974816MYRFLchr12703458932600858GISSRQVVVEGRTDKSKSVLARNALS
PTPRBchr1270974816MYRFLchr12703458932600858GISSRQVVVEGRTEDKSKSVLARNAL
PTPRBchr1270974816MYRFLchr12703458932604859GISSRQVVVEGRTDKSKSVLARNALS
PTPRBchr1270974816MYRFLchr12703458932604859GISSRQVVVEGRTEDKSKSVLARNAL
PTPRBchr1270974816MYRFLchr12703458932623859GISSRQVVVEGRTDKSKSVLARNALS
PTPRBchr1270974816MYRFLchr12703458932623859GISSRQVVVEGRTEDKSKSVLARNAL

Top

Potential FusionNeoAntigen Information of PTPRB-MYRFL in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PTPRB-MYRFL_70974816_70345893.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B41:01TEDKSKSV0.99240.69231220
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B44:03TEDKSKSVL0.9480.93741221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B45:01TEDKSKSVL0.88680.64091221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B18:01TEDKSKSVL0.79070.78281221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:13TEDKSKSVL0.77030.79071221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:01TEDKSKSVL0.73670.79481221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B38:02TEDKSKSVL0.73510.86381221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B15:10TEDKSKSVL0.69490.52011221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B41:01TEDKSKSVL0.61750.70611221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B50:01TEDKSKSVL0.54820.63771221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B45:01TEDKSKSVLA0.97460.66491222
PTPRB-MYRFLchr1270974816chr12703458931954HLA-A30:08RTDKSKSVLA0.85660.55911121
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B41:01TEDKSKSVLA0.83270.73221222
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B50:01TEDKSKSVLA0.81650.69021222
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:13RTEDKSKSVL0.49510.73551121
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:13GRTEDKSKSVL0.99840.65121021
PTPRB-MYRFLchr1270974816chr12703458931954HLA-A74:09RTDKSKSVLAR0.98690.60851122
PTPRB-MYRFLchr1270974816chr12703458931954HLA-A74:11RTDKSKSVLAR0.98690.60851122
PTPRB-MYRFLchr1270974816chr12703458931954HLA-A74:03RTDKSKSVLAR0.98690.60851122
PTPRB-MYRFLchr1270974816chr12703458931954HLA-A30:08RTEDKSKSVLA0.89850.70171122
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C05:09RTDKSKSV0.99990.73321119
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C08:15RTDKSKSV0.99940.79621119
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:08TEDKSKSV0.99120.75591220
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C04:10RTDKSKSVL0.99990.74521120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C05:09RTDKSKSVL0.99990.85521120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C04:07RTDKSKSVL0.99990.7851120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C08:15RTDKSKSVL0.99980.94061120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C01:17RTDKSKSVL0.99950.90561120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C03:07RTDKSKSVL0.99280.91651120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C15:06RTDKSKSVL0.99270.79641120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C03:19RTDKSKSVL0.98970.94821120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C15:06RTEDKSKSV0.98940.90631120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C03:08RTDKSKSVL0.98860.7811120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C01:30RTDKSKSVL0.97370.89891120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C04:06RTDKSKSVL0.97040.63611120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C08:04RTDKSKSVL0.94780.85551120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C08:13RTDKSKSVL0.94780.85551120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C04:14RTDKSKSVL0.93890.76811120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B14:03TEDKSKSVL0.89510.70261221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:08TEDKSKSVL0.88420.76531221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C02:06RTDKSKSVL0.84210.85361120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:08RTDKSKSVL0.79490.65981120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:05TEDKSKSVL0.74640.77831221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C08:03RTDKSKSVL0.74050.94841120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C12:16GRTDKSKSV0.00080.87041019
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:08RTEDKSKSVL0.92880.72961121
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:08GRTEDKSKSVL0.99510.75231021
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C05:01RTDKSKSV0.99990.73321119
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C08:02RTDKSKSV0.99940.79621119
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C05:01RTDKSKSVL0.99990.85521120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C04:01RTDKSKSVL0.99990.7851120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C04:03RTDKSKSVL0.99990.81341120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C18:01RTDKSKSVL0.99980.79681120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C01:03RTDKSKSVL0.99980.84941120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C08:02RTDKSKSVL0.99980.94061120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C01:02RTDKSKSVL0.99960.90481120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C18:01TEDKSKSVL0.99950.80781221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B40:04TEDKSKSVL0.99920.5571221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B27:09GRTDKSKSV0.99810.61551019
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B27:06GRTDKSKSV0.99810.56151019
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C15:02RTEDKSKSV0.99150.87541120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C15:05RTEDKSKSV0.99060.87861120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C15:05RTDKSKSVL0.990.78381120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C15:02RTDKSKSVL0.98750.7471120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C03:03RTDKSKSVL0.98670.96341120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C03:04RTDKSKSVL0.98670.96341120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C03:17RTDKSKSVL0.98180.93581120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C03:05RTDKSKSVL0.97790.87011120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C16:02RTDKSKSVL0.96930.97651120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B44:13TEDKSKSVL0.9480.93741221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B44:26TEDKSKSVL0.9480.93741221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B44:07TEDKSKSVL0.9480.93741221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:11TEDKSKSVL0.87240.72691221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C03:06RTDKSKSVL0.82620.96171120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B18:05TEDKSKSVL0.79070.78281221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:02TEDKSKSVL0.75750.79491221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B18:08TEDKSKSVL0.74380.65251221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:31TEDKSKSVL0.74330.79571221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C08:01RTDKSKSVL0.74050.94841120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B18:03TEDKSKSVL0.70920.76661221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B07:13RTDKSKSVL0.70040.73921120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C06:08GRTDKSKSV0.69560.94871019
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B18:11TEDKSKSVL0.69360.78691221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B50:04TEDKSKSVL0.54820.63771221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B50:05TEDKSKSVL0.54820.63771221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B15:09TEDKSKSVL0.54430.53241221
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C07:04GRTDKSKSV0.51970.86041019
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B57:02RTDKSKSVL0.46430.79081120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C17:01RTDKSKSVL0.43860.75911120
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C06:02GRTDKSKSV0.00720.94481019
PTPRB-MYRFLchr1270974816chr12703458931954HLA-C06:17GRTDKSKSV0.00720.94481019
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B27:06GRTDKSKSVL0.9980.50841020
PTPRB-MYRFLchr1270974816chr12703458931954HLA-A30:01RTDKSKSVLA0.87430.68541121
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B50:04TEDKSKSVLA0.81650.69021222
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B50:05TEDKSKSVLA0.81650.69021222
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B39:02RTEDKSKSVL0.65540.73441121
PTPRB-MYRFLchr1270974816chr12703458931954HLA-B40:04RTEDKSKSVL0.50940.6921121
PTPRB-MYRFLchr1270974816chr12703458931954HLA-A74:01RTDKSKSVLAR0.98690.60851122
PTPRB-MYRFLchr1270974816chr12703458931954HLA-A30:01RTEDKSKSVLA0.91250.81351122

Top

Potential FusionNeoAntigen Information of PTPRB-MYRFL in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PTPRB-MYRFL_70974816_70345893.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0315SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0324SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0801SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0805SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0805SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0806SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0806SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0810SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0810SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0812SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0816SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0818SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0818SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0822SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0822SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0826SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0829SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0839SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0840SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0840SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0840ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-0840RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1134SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1150SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1153SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1156SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1179SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1183SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1183SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1188SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1303SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1303SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1303ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1303RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1304SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-13101SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-13101SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-13101ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-13101RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1310SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1310SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1310ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1310RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1312SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1312SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1312ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1312RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1313SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1313SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1321SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1330SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1330SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1332SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1332SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1333SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1333SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1333ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1333RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1337SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1338SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1338SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1344SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1348SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1348SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1349SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1349SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1355SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1358SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1358SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1358ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1358RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1365SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1365SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1366SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1366SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1366ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1366RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1375SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1381SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1381SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1381ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1381RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1388SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1388SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1388ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1388RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1389SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1389SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1389ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1389RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1390SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1390SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1390ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1390RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1393SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1394SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1394SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1394ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1394RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1395SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1395SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1395ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1395RQVVVEGRTEDKSKS419
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1409SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1413SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1413SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1417SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1421SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1421SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1422SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1422SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1425SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1425SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1433SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1433SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1437SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1465SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1465SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1469SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1469SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1473SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1474SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1474SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1474ISSRQVVVEGRTEDK116
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1478SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1480SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1480SSRQVVVEGRTEDKS217
PTPRB-MYRFLchr1270974816chr12703458931954DRB1-1485SRQVVVEGRTEDKSK318
PTPRB-MYRFLchr1270974816chr12703458931954DRB4-0101RQVVVEGRTDKSKSV419
PTPRB-MYRFLchr1270974816chr12703458931954DRB4-0103RQVVVEGRTDKSKSV419
PTPRB-MYRFLchr1270974816chr12703458931954DRB4-0104RQVVVEGRTDKSKSV419
PTPRB-MYRFLchr1270974816chr12703458931954DRB4-0106RQVVVEGRTDKSKSV419
PTPRB-MYRFLchr1270974816chr12703458931954DRB4-0107RQVVVEGRTDKSKSV419
PTPRB-MYRFLchr1270974816chr12703458931954DRB4-0108RQVVVEGRTDKSKSV419

Top

Fusion breakpoint peptide structures of PTPRB-MYRFL

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10381VVVEGRTDKSKSVLPTPRBMYRFLchr1270974816chr12703458931954
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10382VVVEGRTEDKSKSVPTPRBMYRFLchr1270974816chr12703458931954

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of PTPRB-MYRFL

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN10381VVVEGRTDKSKSVL-7.9962-8.1096
HLA-B14:023BVN10381VVVEGRTDKSKSVL-5.70842-6.74372
HLA-B52:013W3910381VVVEGRTDKSKSVL-6.83737-6.95077
HLA-B52:013W3910381VVVEGRTDKSKSVL-4.4836-5.5189
HLA-A11:014UQ210381VVVEGRTDKSKSVL-10.0067-10.1201
HLA-A11:014UQ210381VVVEGRTDKSKSVL-9.03915-10.0745
HLA-A24:025HGA10381VVVEGRTDKSKSVL-6.56204-6.67544
HLA-A24:025HGA10381VVVEGRTDKSKSVL-5.42271-6.45801
HLA-B44:053DX810381VVVEGRTDKSKSVL-7.85648-8.89178
HLA-B44:053DX810381VVVEGRTDKSKSVL-5.3978-5.5112
HLA-B35:011A1N10381VVVEGRTDKSKSVL-6.27422-6.38762
HLA-B35:011A1N10381VVVEGRTDKSKSVL-5.27424-6.30954
HLA-A02:016TDR10381VVVEGRTDKSKSVL-3.37154-4.40684
HLA-B14:023BVN10382VVVEGRTEDKSKSV-7.9962-8.1096
HLA-B14:023BVN10382VVVEGRTEDKSKSV-5.70842-6.74372
HLA-B52:013W3910382VVVEGRTEDKSKSV-6.83737-6.95077
HLA-B52:013W3910382VVVEGRTEDKSKSV-4.4836-5.5189
HLA-A11:014UQ210382VVVEGRTEDKSKSV-10.0067-10.1201
HLA-A11:014UQ210382VVVEGRTEDKSKSV-9.03915-10.0745
HLA-A24:025HGA10382VVVEGRTEDKSKSV-6.56204-6.67544
HLA-A24:025HGA10382VVVEGRTEDKSKSV-5.42271-6.45801
HLA-B44:053DX810382VVVEGRTEDKSKSV-7.85648-8.89178
HLA-B44:053DX810382VVVEGRTEDKSKSV-5.3978-5.5112
HLA-B35:011A1N10382VVVEGRTEDKSKSV-6.27422-6.38762
HLA-B35:011A1N10382VVVEGRTEDKSKSV-5.27424-6.30954
HLA-A02:016TDR10382VVVEGRTEDKSKSV-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of PTPRB-MYRFL

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
PTPRB-MYRFLchr1270974816chr12703458931019GRTDKSKSVGAAGAACAGACAAAAGCAAATCAGTTT
PTPRB-MYRFLchr1270974816chr12703458931020GRTDKSKSVLGAAGAACAGACAAAAGCAAATCAGTTTTGG
PTPRB-MYRFLchr1270974816chr12703458931021GRTEDKSKSVLGAAGAACAGAAGACAAAAGCAAATCAGTTTTGG
PTPRB-MYRFLchr1270974816chr12703458931119RTDKSKSVGAACAGACAAAAGCAAATCAGTTT
PTPRB-MYRFLchr1270974816chr12703458931120RTDKSKSVLGAACAGACAAAAGCAAATCAGTTTTGG
PTPRB-MYRFLchr1270974816chr12703458931120RTEDKSKSVGAACAGAAGACAAAAGCAAATCAGTTT
PTPRB-MYRFLchr1270974816chr12703458931121RTDKSKSVLAGAACAGACAAAAGCAAATCAGTTTTGGCAA
PTPRB-MYRFLchr1270974816chr12703458931121RTEDKSKSVLGAACAGAAGACAAAAGCAAATCAGTTTTGG
PTPRB-MYRFLchr1270974816chr12703458931122RTDKSKSVLARGAACAGACAAAAGCAAATCAGTTTTGGCAAGAA
PTPRB-MYRFLchr1270974816chr12703458931122RTEDKSKSVLAGAACAGAAGACAAAAGCAAATCAGTTTTGGCAA
PTPRB-MYRFLchr1270974816chr12703458931220TEDKSKSVCAGAAGACAAAAGCAAATCAGTTT
PTPRB-MYRFLchr1270974816chr12703458931221TEDKSKSVLCAGAAGACAAAAGCAAATCAGTTTTGG
PTPRB-MYRFLchr1270974816chr12703458931222TEDKSKSVLACAGAAGACAAAAGCAAATCAGTTTTGGCAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
PTPRB-MYRFLchr1270974816chr1270345893116ISSRQVVVEGRTEDKTCTCTTCCCGACAAGTGGTTGTGGAGGGAAGAACAGAAGACAAAA
PTPRB-MYRFLchr1270974816chr1270345893217SSRQVVVEGRTEDKSCTTCCCGACAAGTGGTTGTGGAGGGAAGAACAGAAGACAAAAGCA
PTPRB-MYRFLchr1270974816chr1270345893318SRQVVVEGRTEDKSKCCCGACAAGTGGTTGTGGAGGGAAGAACAGAAGACAAAAGCAAAT
PTPRB-MYRFLchr1270974816chr1270345893419RQVVVEGRTDKSKSVGACAAGTGGTTGTGGAGGGAAGAACAGACAAAAGCAAATCAGTTT
PTPRB-MYRFLchr1270974816chr1270345893419RQVVVEGRTEDKSKSGACAAGTGGTTGTGGAGGGAAGAACAGAAGACAAAAGCAAATCAG

Top

Information of the samples that have these potential fusion neoantigens of PTPRB-MYRFL

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADPTPRB-MYRFLchr1270974816ENST00000261266chr1270345893ENST00000299350TCGA-BR-A44T-01A
STADPTPRB-MYRFLchr1270974816ENST00000261266chr1270345893ENST00000547771TCGA-BR-A44T-01A

Top

Potential target of CAR-T therapy development for PTPRB-MYRFL

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to PTPRB-MYRFL

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PTPRB-MYRFL

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource